Literature DB >> 15306397

Management and prevention of SARS in China.

Nanshan Zhong1.   

Abstract

The case fatality was the lowest (3.8%) among 1512 cases with severe acute respiratory syndrome (SARS) in Guangdong Province, China. Rational use of corticosteroid, non-invasive ventilation and the integration of traditional Chinese medicine and modern medicine may partly have contributed to the lowest fatality figure. There was a close linkage between civet cats and humans in terms of transmission of SARS. Strict control of the wild-animal market may be significant in preventing a new outbreak of SARS this year.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15306397      PMCID: PMC1693398          DOI: 10.1098/rstb.2004.1491

Source DB:  PubMed          Journal:  Philos Trans R Soc Lond B Biol Sci        ISSN: 0962-8436            Impact factor:   6.237


  4 in total

Review 1.  Our strategies for fighting severe acute respiratory syndrome (SARS).

Authors:  Nan Shan Zhong; Guang Qiao Zeng
Journal:  Am J Respir Crit Care Med       Date:  2003-05-28       Impact factor: 21.405

2.  Outbreak of severe acute respiratory syndrome in Hong Kong Special Administrative Region: case report.

Authors:  Moira Chan-Yeung; W C Yu
Journal:  BMJ       Date:  2003-04-19

3.  A retrospective study of 78 patients with severe acute respiratory syndrome.

Authors:  Zhenglun Xiao; Yimin Li; Rongchang Chen; Shiyue Li; Shuqing Zhong; Nanshan Zhong
Journal:  Chin Med J (Engl)       Date:  2003-06       Impact factor: 2.628

4.  Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003.

Authors:  N S Zhong; B J Zheng; Y M Li; Z H Xie; K H Chan; P H Li; S Y Tan; Q Chang; J P Xie; X Q Liu; J Xu; D X Li; K Y Yuen; Y Guan
Journal:  Lancet       Date:  2003-10-25       Impact factor: 79.321

  4 in total
  33 in total

1.  Confronting SARS: a view from Hong Kong.

Authors:  J S M Peiris; Y Guan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-07-29       Impact factor: 6.237

2.  Introduction. Emerging infections: what have we learnt from SARS?

Authors:  A R McLean; R M May; J Pattison; R A Weiss
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-07-29       Impact factor: 6.237

Review 3.  Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions.

Authors:  Wenhui Li; Swee-Kee Wong; Fang Li; Jens H Kuhn; I-Chueh Huang; Hyeryun Choe; Michael Farzan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Severe acute respiratory syndrome: a vanished evil?

Authors:  Wei-Jie Guan; Xue-Yan Zheng; Guang-Qiao Zeng; Nan-Shan Zhong
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

Review 5.  Insights from the association of SARS-CoV S-protein with its receptor, ACE2.

Authors:  Wenhui Li; Hyeryun Choe; Michael Farzan
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

Review 6.  Recombination, reservoirs, and the modular spike: mechanisms of coronavirus cross-species transmission.

Authors:  Rachel L Graham; Ralph S Baric
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

7.  Structural analysis of major species barriers between humans and palm civets for severe acute respiratory syndrome coronavirus infections.

Authors:  Fang Li
Journal:  J Virol       Date:  2008-04-30       Impact factor: 5.103

8.  Animal origins of SARS coronavirus: possible links with the international trade in small carnivores.

Authors:  Diana Bell; Scott Roberton; Paul R Hunter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-07-29       Impact factor: 6.237

9.  What have we learnt from SARS?

Authors:  Robin A Weiss; Angela R McLean
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2004-07-29       Impact factor: 6.237

Review 10.  Plants and Natural Products with Activity against Various Types of Coronaviruses: A Review with Focus on SARS-CoV-2.

Authors:  Susana A Llivisaca-Contreras; Jaime Naranjo-Morán; Andrea Pino-Acosta; Luc Pieters; Wim Vanden Berghe; Patricia Manzano; Jeffrey Vargas-Pérez; Fabian León-Tamariz; Juan M Cevallos-Cevallos
Journal:  Molecules       Date:  2021-07-05       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.